Ischemic preconditioning, cardioplegia or both? differing approaches to myocardial and vascular protection

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 3, 1996, Pages 623-634

  Kolocassides, Kyriacos G ^a   Galiañes, Manuel ^a   Hearse, David J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cardioplegia; Coronary vascular injury; Ischemic preconditioning; Myocyte injury

Indexed keywords

SEROTONIN; ST THOMAS HOSPITAL SOLUTION;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

ANIMALIA;

EID: 0342748391     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1994.1159     Document Type: Article

References (36)

1. Barone GW, Conerly MJ, Farley PC, Flanagan TL, Kron IL, 1989. Endothelial injury and vascular dysfunction associated with the Fogarty balloon catheter. J Vasc Surg 9: 422-425.
2. Bauer B, Simkhovich Z, Kloner RA, Pryzlclenk K, 1993. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury? Circulation 88: 659-672.
3. Braimbridge MV, Hearse DJ, Chayen J, Bitensky L, Cankovic-Darracott S, 1978. Cold cardioplegia versus continuous coronary perfusion: clinical and cyto-chemical assessment. In: Longmore DB, ed, Modern Cardiac Surgery. MTP Press Ltd, Lancaster, 286-297.
4. Cave A, Hearse DJ, 1992. Ischemic preconditioning and contractile function: studies with normothermic and hypothermic global ischemia. J Mol Cell Cardiol 24: 1113-1123.
5. Chan BBK, Kron IL, Flanagan TL, Kern JA, Hobson CE, Tribble CG, 1993. Impairment of vascular endothelial function by high-potassium storage solutions. Ann Tho-rac Surg 55: 940-945.
6. Defily DV, Chilian WM, 1993. Preconditioning protects coronary arteriolar endothelium from ischemia-re-perfusion injury. Am J Physiol 265: H700-H706.
7. Evora PR, Pearson PJ, Schaff HV, 1992. Crystalloid cardioplegia and hypothermia do not impair endothelium-dependent relaxation or damage vascular smooth muscle of epicardial coronary arteries. J Thorac Cardiovasc Surg 104: 1365-1374.
8. GaliNanes M, Saldanha C, Kato H, Elliott MJ, De Leval MR, Hearse DJ, 1995. Vascular and contractile function and tissue metabolites after prolonged hypothermic ischaemia and reperfusion: comparison of single- versus multi-dose infusions with two car-dioplegic solutions in blood-perfused neonatal pig hearts. J Mol Cell Cardiol 27: 1915-1930.
9. Harjula A, Mattila S, Mattila I, Harkonen M, Myl-larniemi H, Nickels J, Merikallio E, 1984. Coronary endothelial damage after crystalloid cardioplegia. J Cardiovasc Surg 25: 147-152.
10. Hearse DJ, Braimbridge MV, Jynge P, 1981a. Cardioplegic solutions in clinical use. In: Hearse DJ, Braimbridge MV, Jynge P, eds, Protection of the Ischemic Myocardium: Cardioplegia. Raven Press, New York, 3-18.
11. Hearse DJ, Braimbridge MV, Jynge P, 1981b. Historical review. In: Hearse DJ, Braimbridge MV, Jynge P, eds, Protection of the Ischemic Myocardium: Cardioplegia. Raven Press, New York, 341-352.
12. Hearse DJ, Maxwell L, Saldanha C, Gavin JB, 1993. The myocardial vasculature during ischemia and reperfusion: A target for injury and protection. J Mol Cell Cardiol 25: 759-800.
13. Jacob H, 1981. The role of activated complement and granulocytes in shock states and myocardial infarction. J Lab Clin Med 98: 645-653.
14. Jenkins DP, Pugsley WB, Yellon DM, 1995. Ischemic preconditioning in a model of global ischemia: infarct size limitation, but no reduction in stunning. J Mol Cell Cardiol 27: 1623-1632.
15. Kloner RA, Giacomelli F, Alker KJ, Hale SL, Matthews R, Bellows S, 1991. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 84: 1758-1772.
16. Kloner RA, Rude RE, Carlson N, Maroko PR, Deboer LWV, Braunwald E, 1980. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first? Circulation 62: 945-952.
17. Lawson CS, Coltart DJ, Hearse DJ, 1993. “Dose”-de-pendency and temporal characteristics of protection by ischemic preconditioning against ischemia-induced arrhythmias in rat hearts. J Mol Cell Cardiol 25: 1391-1402.
18. Lawson CS, Downey JM, 1993. Preconditioning: state of the art myocardial protection. Cardiovasc Res 27: 542-550.
19. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR, 1990. Myocardial protection with preconditioning. Circulation 82: 609-619.
20. Lindal S, Sørlie D, Jørgensen L, 1989. Endothelial cells of the cardiac microvasculature during and after cold cardioplegic ischemia: comparison of endothelial and myocyte damage. J Thorac Cardiovasc Surg 37: 151-157.
21. Lucchesi BR, 1994. Complement, neutrophils and free radicals: mediators of reperfusion injury. Arzneimittelforschung 44(3a): 420-432.
22. Mankad PS, Chester AH, Yacoub MH, 1991. 5-Hydroxy-tryptamine mediates endothelium dependent coronary vasodilatation in the isolated rat heart by the release of nitric oxide. Cardiovasc Res 25: 244-248.
23. Mankad PS, Chester AH, Yacoub MH, 1992. Ischemic endothelial dysfunction after single or multidose cardioplegia. Eur Heart J 13: 976-980.
24. Miura T, Adachi T, Ogawa T, Iwamoto T, Tsuchida A, Iimura O, 1992. Myocardial infarct size-limiting effect of ischemic preconditioning: its natural decay and the effect of repetitive preconditioning. Cardiovasc Pathol 1: 147-154.
25. Murry CE, Jennings RB, Reimer KA, 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136.
26. Richard V, Kaeffer N, Tron C, Thuillez C, 1993. Impaired endothelium-dependent relaxations of rat coronary arteries after ischemia and reperfusion: prevention by preconditioning. Circulation 88 [Suppl. I]: I-137.
27. Saldanha C, Hearse DJ, 1989. Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegia solution in the rat heart. Possible evidence of endothelial damage. J Thorac Cardiovasc Surg 98: 783-787.
28. Saldanha C, Hearse DJ, 1994. Cardioplegia and vascular injury: Dissociation of the effect of ischemia from those of the cardioplegic solution. J Thorac Cardiovasc Surg 108: 279-290
29. Sellke FW, Shafique T, Schoen FJ, Weintraub RM, 1993. Impaired endothelium-dependent coronary microvascular relaxation after cold potassium cardioplegia and reperfusion. J Thorac Cardiovasc Surg 105: 52-58.
30. Shandelya SM, Kuppusamy P, Weisfeldt ML, Zweier JL, 1993. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury. Evidence for plasma-mediated leukocyte activation. Circulation 87: 536-546.
31. Shiki K, Hearse DJ, 1987. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol 253: H1470-H1476.
32. Vanhoutte PM, 1986. Could the absence or malfunction of vascular endothelium precipitate the occurrence of vasospasm? J Mol Cell Cardiol 18: 679-686.
33. Vanhoutte PM, Houston DS, 1985. Platelets, endothelium and vasospasm. Circulation 72: 728-734.
34. Wright JEC, 1981. Changing aspects of surgical technique in coronary artery surgery. In: Longmore DB, ed, Towards Safer Cardiac Surgery. MTP Press Ltd, Lancaster, 81-94.
35. Yellon DM, Alkhulaifi AM, Pugsley WB, 1993. Preconditioning the human myocardium. Lancet 342: 276-277.
36. Zhai X, Lawson CS, Cave A, Hearse DJ, 1993. Preconditioning and post-ischemic contractile dysfunction: the role of impaired oxygen delivery vs extracellular metabolite accumulation. J Mol Cell Cardiol 25: 847-857.